FREE Account Opening + No Clearing Fees
Loading...

A M Febcon vs ANG Lifesciences IPO

Comparision between A M Febcon and ANG Lifesciences IPO.

IPO Details

A M Febcon is a SME Fixed Price Issue IPO proposed to list at BSE SME while ANG Lifesciences IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  A M Febcon ANG Lifesciences IPO
Logo A M Febcon Logo ANG Lifesciences IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME BSE SME
Lead Managers Gretex Corporate Services Limited Oneview Corporate Advisors Pvt. Ltd.
Registrar Kfin Technologies Limited Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of A M Febcon is up to ₹6.68 Cr whereas the issue size of the ANG Lifesciences IPO is up to ₹12.01 Cr. The final issue price of A M Febcon is ₹18.00 per share and of ANG Lifesciences IPO is ₹80.00 per share.

  A M Febcon ANG Lifesciences IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹18.00 per share ₹80.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 8000 shares 1600 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 37,12,000 shares 15,00,800 shares
Issue Size Total (Amount) up to ₹6.68 Cr up to ₹12.01 Cr

IPO Timetable

A M Febcon opens on Sep 01, 2017, while ANG Lifesciences IPO opens on Aug 29, 2017. The closing date of A M Febcon and ANG Lifesciences IPO is Sep 06, 2017, and Aug 31, 2017, respectively.

  A M Febcon ANG Lifesciences IPO
Anchor Bid Date
Issue Open Sep 01, 2017 Aug 29, 2017
Issue Close Sep 06, 2017 Aug 31, 2017
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

A M Febcon P/E ratio is , as compared to ANG Lifesciences IPO P/E ratio of .

  A M Febcon ANG Lifesciences IPO
Financial
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the A M Febcon retail investors (RII) are offered 18,56,000 shares while in ANG Lifesciences IPO retail investors are offered 18,56,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in A M Febcon and 0 shares in ANG Lifesciences IPO.

  A M Febcon ANG Lifesciences IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 0 shares 0 shares
NII 18,56,000 shares 7,12,000 shares
RII 18,56,000 shares 7,12,000 shares
Employee
Others
Total 37,12,000 shares 14,24,000 shares

Bids Received (Subscription)

A M Febcon subscribed in total, whereas ANG Lifesciences IPO subscribed .

  A M Febcon ANG Lifesciences IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Comments

Add a public comment...